Cero Therapeutics Holdings, Inc.
Biological Products, (No Diagnostic Substances) · South San Francisco, CA, United States
- PrincipalsAndrew Albert KucharchukChief Financial OfficerChristopher B EhrlichChairman and CEOKristen PierceChief Development Officerand 5 more
- CompanyCero Therapeutics Holdings, Inc.South San Francisco, CA, United States
- Phone line+1 (650) 407-2376General business
Cero Therapeutics Holdings, Inc. is an SEC-registered OTC-listed company (ticker CERO) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 8
Chief executive
Christopher B EhrlichChairman and CEO
Chair & board
Brian G AtwoodDirector (Board)
Kathleen LaporteDirector (Board)
Lindsey RolfeDirector (Board)
Michael ByrnesDirector (Board)
Finance
Andrew Albert KucharchukChief Financial Officer
Everyone else on file (1)
Kristen PierceChief Development Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Andrew Albert Kucharchuk — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Christopher B Ehrlich — Chairman and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Kristen Pierce — Chief Development Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Brian G Atwood — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Crispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityTarget Group Inc.Medicinal Chemicals & Botanical Products · Hamilton1 shared capability